Considering that our FCCS studies of CT-179 confirmed the predicted mechanism of OLIG2 inhibition and that CT-179 showed low off-target effects and the favorable PK, we analyzed the anti-tumor potential of CT-179 in live cells in culture. Here, OLIG2 is linked to neoplasm.